News | Stereotactic Body Radiation Therapy (SBRT) | February 12, 2021

 

Demand for next-gen brain tumor treatment technology exceeds expectations

ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform.

February 12, 2021 — ZAP Surgical Systems, Inc. announced 18 new system orders in 2020 for its recently commercialized ZAP-X Gyroscopic Radiosurgery platform. The news marks an extraordinary increase in year-over-year order volume. Having recently launched a robust global infrastructure, orders originated from both hospital and free-standing centers in the United States, Germany, Italy, Switzerland, Japan and other countries.

“ZAP started 2020 with highly ambitious goals. By mid-year however, COVID dashed many hopes of achieving those original plans,” said Richard Rosene, executive vice president of global sales and marketing. “The market has obviously responded favorably to ZAP-X, and we’re incredibly grateful to have surpassed global pre-pandemic sales targets for the year. Given the COVID challenges faced by our customers in the hospital and private sectors, it’s a remarkable accomplishment.”

Stereotactic radiosurgery (SRS) is a well-studied and effective treatment for many brain cancers including primary and metastatic brain tumors. Considered an alternative to surgery for many such indications, SRS is an outpatient procedure that often provides equivalent outcomes, yet requires no surgical incision, and little to no patient recovery period.

ZAP-X is also acclaimed for being the first and only vault-free SRS delivery system, thus typically eliminating the need for costly shielded radiation treatment rooms. Deploying a modern linear accelerator to produce radiation, ZAP-X also obviates the regulatory and heightened security requirements for providers to host live radioactive isotopes within their clinics.

“Historically, the associated costs and complexities of delivering SRS meant the vast majority of radiosurgery occurred primarily in the largest, most well-funded academic hospitals. We estimate this paradigm has left nearly 90% of potential SRS patient candidates without adequate access,” said John Adler, M.D., CEO of ZAP Surgical Systems, and professor emeritus of neurosurgery and radiation oncology at Stanford University. “ZAP-X has effectively broken down those barriers to now make it feasible to bring world-class SRS to more patients in more places.”

For more information: www.zapsurgical.com

Related Brain Radiotherapy Content:

VIDEO: Use of a Fully Self-contained Brain Radiotherapy System

New Radiotherapy and Medical Physics Technology at AAPM 2019

 


Related Content

News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Artificial Intelligence

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
arrow
News | Breast Imaging

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
News | Radiopharmaceuticals and Tracers

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
News | Information Technology

June 4, 2024 — International medical imaging IT and cybersecurity company Sectra has launched a new diagnostic IT module ...

Time June 04, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now